Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan

Allergan plc’s AGN second-quarter 2018 earnings came in at $4.42 per share, which comprehensively beat the Zacks Consensus Estimate of $4.13 and came ahead of the guided range of $4-$4.20. Earnings rose 10% year over year driven by higher revenues and lower operating costs.